The majority of fatal cases of malaria are caused by infection with the parasite Plasmodium falciparum. Most at risk are young children and women who are pregnant. A team of researchers, led by Patrick Duffy, at the National ...
Biotechnology
Feb 7, 2011
0
0
An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists. ...
Cell & Microbiology
Nov 30, 2020
0
16
Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever, a serious health threat resulting in some 22 million new cases yearly and approximately 217,000 fatalities. A number of novel vaccine candidates using live ...
Cell & Microbiology
Jun 28, 2012
0
0
Researchers have used plants to produce virus-like particles (VLPs) of the dengue virus in a potential first step towards novel vaccines against the growing threat.
Biotechnology
Dec 3, 2020
0
39
An experimental vaccine applied the surface of the skin appears to protect against certain types of ear infections. Scientists from the Research Institute at Nationwide Children's Hospital in Columbus, Ohio, report their ...
Cell & Microbiology
May 21, 2009
0
0
For the most part, the bacterium Staphylococcus aureus is common and harmless, posing no threat to humans with whom they coexist. Occasionally, though, it can become an opportunistic pathogen, causing skin and bloodstream ...
Cell & Microbiology
Jul 7, 2022
0
46
The Vaccine Group, a University of Plymouth spinout company, has successfully completed a project to develop a transmissible vaccine for use in the rats that spread Lassa fever and to reduce its threat to humans.
Ecology
Dec 6, 2022
0
2
